Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Oct 27, 2014 01:57 PM Roth Capital 'Impressed' with Ligand's (LGND) Q3 Results; Affirms at 'Buy'
Oct 27, 2014 08:05 AM Form 8-K LIGAND PHARMACEUTICALS For: Oct 27
Oct 27, 2014 08:01 AM Ligand Pharma (LGND) Tops Q3 EPS by 5c; Guides Q4, FY14
Oct 27, 2014 08:00 AM Ligand Reports Third Quarter 2014 Financial Results
Oct 24, 2014 12:07 PM Streetinsider.com's Hot Lunchtime Reads 10/24: (SODA) (TSLA) (AMT) (MSFT)
Oct 24, 2014 11:15 AM Ligand's (LGND) Duavee Will be Significant N-T Revenue Driver; CHMP Opinion is Encouraging - Roth
Oct 23, 2014 08:45 AM Roth Capital Lifts PT on Ligand (LGND) 32% Ahead of Q3 Results
Oct 22, 2014 08:40 AM Roth Affirms Ligand (LGND) at 'Buy' Following Strong Promacta Sales in Q3
Oct 16, 2014 08:30 AM Ligand to Host Analyst Day on November 18th in New York City
Oct 15, 2014 07:03 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 15 Filed by: KOZARICH JOHN W
Oct 14, 2014 01:49 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 10 Filed by: FOEHR MATTHEW W
Oct 10, 2014 03:04 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: Sabba Stephen L
Oct 10, 2014 02:29 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: KNOTT DAVID M
Oct 9, 2014 07:04 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 09 Filed by: Aryeh Jason
Oct 9, 2014 01:50 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 07 Filed by: KOZARICH JOHN W
Oct 8, 2014 10:22 AM Roth Maintains Ligand Pharma (LGND) at 'Buy' Following Prelim. Q3 Results
Oct 8, 2014 08:31 AM Ligand Pharma (LGND) Prelim. Q3 Revs, EPS Top Views
Oct 8, 2014 08:30 AM Ligand Reports Third Quarter Revenues and Expected Diluted EPS
Oct 2, 2014 03:00 PM Lemelson Capital Management Fund Tops BarclayHedge Performance List
Oct 1, 2014 06:25 PM Form 4 LIGAND PHARMACEUTICALS For: Oct 01 Filed by: Aryeh Jason
Sep 29, 2014 01:50 PM Form 4 LIGAND PHARMACEUTICALS For: Sep 25 Filed by: Aryeh Jason
Sep 26, 2014 08:30 AM Ligand Earns Milestone Payment Triggered by EU Approval of Merck’s Captisol-enabled NOXAFIL® (posaconazole) Concentrate for Solution for Infusion
Sep 9, 2014 03:33 PM Roth Keeps Ligand (LGND) at 'Buy' Following New Captisol-Based Tech Launch
Sep 9, 2014 08:37 AM Ligand Pharma (LGND) Reports Expanded License Agreement with CURx Pharma
Sep 9, 2014 08:30 AM Ligand Licenses Captisol-enabled™ Lamotrigine to CURx Pharmaceuticals, Inc.
Sep 5, 2014 09:03 AM Lemelson Capital Management Marks Flagship Fund's Second Anniversary
Aug 28, 2014 11:11 AM Interferon Therapy for HCV Still Expected Strong Amid Daklinza Approval - Roth (LGND) (BMY)
Aug 27, 2014 09:26 AM Roth Comments on Ligand (LGND) Following Approval of Promact sNDA (GSK)
Aug 27, 2014 08:46 AM Ligand Pharma (LGND) Reports FDA Approval of Promacta/Revolade sNDA
Aug 27, 2014 08:00 AM Ligand Partner GlaxoSmithKline Receives U.S. FDA Approval for Promacta®/Revolade™ For Use in Patients with Severe Aplastic Anemia
Aug 25, 2014 11:48 AM Lemelson Capital Comments on Ligand Pharmaceuticals (LGND) Going Concern Risk
Aug 25, 2014 11:43 AM Lemelson Capital Comments on Large Institutional Selling in Shares of Ligand Pharmaceuticals Amidst Company's Insolvency and Mounting Going Concern Risk
Aug 21, 2014 05:13 PM Form SC 13G/A LIGAND PHARMACEUTICALS Filed by: BIOTECHNOLOGY VALUE FUND L P
Aug 18, 2014 05:17 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 15, 2014 02:52 PM Form 4 LIGAND PHARMACEUTICALS For: Aug 15 Filed by: HIGGINS JOHN L
Aug 15, 2014 09:30 AM Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products
Aug 14, 2014 10:57 AM Roth Remains Positive on Ligand Pharma (LNGD) Following New Licensing Agreement with Avion Pharma
Aug 14, 2014 09:15 AM Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy
Aug 14, 2014 08:01 AM Ligand Pharma (LGND), Avion Pharma Enter Commercial Licensing Arrangement Covering Captisol-Enabled Programs
Aug 14, 2014 08:00 AM Ligand Signs Multi-Program Captisol® License Agreement with Avion Pharmaceuticals
Aug 13, 2014 08:28 AM Form 8-K LIGAND PHARMACEUTICALS For: Aug 12
Aug 13, 2014 08:08 AM Ligand Pharma (LGND) Prices $225M in Conv. Senior Notes; to Buyback ~700K Shares
Aug 13, 2014 08:00 AM Ligand Prices Offering of $225 Million of Convertible Senior Notes
Aug 12, 2014 07:35 AM Marinus Pharma (MRNS) Enters Agreement for Use of Captisol (LGND)
Aug 11, 2014 05:04 PM Form 8-K LIGAND PHARMACEUTICALS For: Aug 11
Aug 11, 2014 04:03 PM Ligand Pharma (LGND) Announces $225M Convetible Notes Offering; Approves $200M Buyback
Aug 11, 2014 04:01 PM Ligand Announces Proposed Offering of $225 Million of Convertible Senior Notes and Announces $200 Million Share Repurchase Program
Aug 5, 2014 05:22 PM Form 10-Q LIGAND PHARMACEUTICALS For: Jun 30
Aug 4, 2014 02:49 PM Lemelson Increases Short Bet on Ligand Pharma (LGND)
Aug 4, 2014 02:46 PM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Updates LGND Research Report with New Material Information

Back to LGND Stock Lookup